|
Volumn 23, Issue 5, 2013, Pages 1228-1231
|
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists
|
Author keywords
CCR1; Chemokine receptor antagonists; Chemokines; Multiple myeloma; Pyrazoles; Rheumatoid arthritis
|
Indexed keywords
1 (4 PHENYLPIPERAZIN 1 YL) 2(1H PYRAZOL 1 YL)ETHANONE;
CHEMOKINE RECEPTOR ANTAGONIST;
CHEMOKINE RECEPTOR CCR1;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
HIGH THROUGHPUT SCREENING;
HUMAN;
HUMAN CELL;
NONHUMAN;
RAT;
RECEPTOR BINDING;
STRUCTURE ACTIVITY RELATION;
CELL LINE;
HUMANS;
PIPERAZINES;
PYRAZOLES;
RECEPTORS, CCR1;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84873727207
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.01.005 Document Type: Article |
Times cited : (16)
|
References (11)
|